Centiva Capital’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-8,495
Closed -$336K 1903
2025
Q1
$336K Buy
8,495
+2,204
+35% +$97.5K 0.01% 1022
2024
Q4
$256K Sell
6,291
-3,222
-34% -$134K 0.01% 1232
2024
Q3
$371K Sell
9,513
-2,583
-21% -$103K 0.01% 1446
2024
Q2
$529K Buy
12,096
+4,463
+58% +$216K 0.01% 1116
2024
Q1
$364K Buy
+7,633
New +$343K 0.01% 1150
2022
Q2
Sell
-3,512
Closed -$225K 1889
2022
Q1
$225K Buy
+3,512
New +$235K ﹤0.01% 1259
2021
Q1
Sell
-4,154
Closed -$315K 1342
2020
Q4
$315K Buy
+4,154
New +$271K 0.01% 638
2020
Q3
Sell
-10,319
Closed -$542K 824
2020
Q2
$542K Sell
10,319
-644
-6% -$30.6K 0.03% 272
2020
Q1
$386K Buy
10,963
+8,022
+273% +$469K 0.02% 351
2019
Q4
$257K Buy
+2,941
New +$257K 0.01% 600

Other funds holding NGVT

Centiva Capital's NGVT Position: Q2 2025 in Review

Centiva Capital sold out of Ingevity (NGVT) in Q2 2025, closing a stake of 8,495 shares — an estimated $336K sold.

Centiva Capital first reported a position in NGVT in Q4 2019 and held it in 10 quarters. The position peaked at $542K in Q2 2020. 269 funds tracked by Wall St. Rank hold NGVT as of Q2 2025.

  • Centiva Capital reported no remaining Ingevity position as of Q2 2025 after selling out during the quarter.
  • Centiva Capital sold 8,495 Ingevity shares in Q2 2025, an estimated $336K.
  • Centiva Capital first reported a position in Ingevity in Q4 2019 and held it in 10 quarters.
  • Centiva Capital's Ingevity position peaked at $542K in Q2 2020.
  • 269 funds tracked by Wall St. Rank held Ingevity as of Q2 2025.

Based on Centiva Capital's 13F filing for Q2 2025, filed 13 Aug 2025.